TAS-102 and the quest for predictive biomarkers.

about

Efficacy and safety of TAS-102 in refractory metastatic colorectal cancer: a meta-analysis

P2860

Q58698641-F89B841B-CD44-4005-9924-651244C47A11

P2860

TAS-102 and the quest for predictive biomarkers.

Item

http://www.wikidata.org/entity/Q55389129

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

TAS-102 and the quest for predictive biomarkers.

@en

TAS-102 and the quest for predictive biomarkers.

@nl

type

Item

label

TAS-102 and the quest for predictive biomarkers.

@en

TAS-102 and the quest for predictive biomarkers.

@nl

prefLabel

TAS-102 and the quest for predictive biomarkers.

@en

TAS-102 and the quest for predictive biomarkers.

@nl

P1476

TAS-102 and the quest for predictive biomarkers.

@en

P2093

Daphne L van der Velden

http://www.w3.org/2001/XMLSchema#string

Frans L Opdam

http://www.w3.org/2001/XMLSchema#string

P2860

Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial

Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group.

A role for DNA mismatch repair in sensing and responding to fluoropyrimidine damage.

Predictive value of chemotherapy-induced neutropenia for the efficacy of oral fluoropyrimidine S-1 in advanced gastric carcinoma.

Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis.

Microsatellite instability does not predict the efficacy of chemotherapy in metastatic colorectal cancer. A systematic review and meta-analysis.

TAS-102, a novel antitumor agent: a review of the mechanism of action.

Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer.

Carcinoembryonic antigen expression level as a predictive factor for response to 5-fluorouracil in colorectal cancer.

Effect of Incorporation of Pretreatment Serum Carcinoembryonic Antigen Levels Into AJCC Staging for Colon Cancer on 5-Year Survival.

P304

e000263

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1136/ESMOOPEN-2017-000263

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29018579

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

5623337

http://www.w3.org/2001/XMLSchema#string

TAS-102 and the quest for predictive biomarkers.

about

P2860

P2860

TAS-102 and the quest for predictive biomarkers.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932